Morin hydrate inhibits azo-initiator induced oxidation of human low density lipoprotein.
T W Wu, K P Fung, J Wu, C C Yang, J Lo, R D Weisel
Index: Life Sci. 58 , PL17-PL22, (1996)
Full Text: HTML
Abstract
We demonstrated that the flavonoid morin hydrate at 75-100 microM protects against the oxidation of low density lipoprotein (LDL) by free radicals produced by 2,2'-azo-bis(2-amidinopropane) dihydrochloride. Morin hydrate reduces the relative electrophoretic mobility, malondialdehyde equivalents and lipid peroxide level of oxidized LDL. On the other hand, Trolox (an analogue of vitamin E) showed less protective effect in the present system. Since free radical mediated oxidation of LDL is implicated to be a cause of atherogenesis, morin hydrate may be a candidate chemotherapeutic agent herein.
Related Compounds
Related Articles:
2014-11-19
[Sci. Transl. Med. 6(263) , 263ra161, (2014)]
2014-10-01
[Int. Immunopharmacol. 22(2) , 356-65, (2014)]
Drug screening boosted by hyperpolarized long-lived states in NMR.
2014-11-01
[ChemMedChem 9(11) , 2509-15, (2014)]
Al adjuvants can be tracked in viable cells by lumogallion staining.
2015-07-01
[J. Immunol. Methods 422 , 87-94, (2015)]
Molecular properties and myocardial salvage effects of morin hydrate.
1995-02-14
[Biochem. Pharmacol. 49 , 537-543, (1995)]